Biotech, cancer, Inflammation Luke Timmerman wrote: Some members of the band that pumped out a one-hit wonder at Icos are getting back together to see if they can produce at least one more hit at Seattle-based Calistoga Pharmaceuticals. Calistoga has been building up its management team over the pas...

Biotech, cancer, Layoffs Luke Timmerman wrote: Seattle-based Oncothyreon (NASDAQ: ONTY) made a series of strategic moves today to preserve its remaining cash, and find a way to survive on its own as a developer of cancer drugs. Some investors liked the decision, as shares more than doubled from 73 c...